Friday, October 18
6:00pm - 10:00pm
Where Are We Now in the Management of Eosinophilic Esophagitis? Controversies and Catalysts
Program Director: Rod Smith, Scientific Director, Medscape
The goal of this activity is to update pediatric gastroenterologists on diagnosis, management, and emerging treatments for EoE.
Three faculty will engage in an interactive multi-format symposium, incorporating debate-style and Roundtable Panel Discussion presentation approaches, with a focus on the pediatric population. The following is the proposed content focus:
Assessment of participant baseline knowledge, competence, and confidence on EoE answered using iPads; this may include a pediatric case of EoE with questions on guideline-based care (eg, from diagnosis to management)
Debating the pathogenesis of EoE
- Is there variability between children and adults, race and gender?
- Is EoE a progressive disease vs subtypes?
- Can phenotypes be used to predict prognosis or therapeutic response?
Is diagnosis straightforward or are there still controversies?
- Controversies related to PPI use and a discussion on updates in diagnostic criteria and steps for diagnosis, with a focus on the pediatric population
Headlines in EoE: A Roundtable Panel Discussion on the current and emerging management of EoE, which may include the role of
- Dietary modifications
- Clinical data on topical and systemic glucocorticoids
- Emerging treatments, clinical trial design, and the latest clinical data
- The role of various HCPs in diagnosis and management: from the pediatric gastroenterologist to the allergist/clinical immunologist
Conclusions and Q&A
Upon completion of this activity, learners will have
- Increased knowledge regarding the
- Pathogenesis of EoE
- Clinical presentations of EoE in the pediatric population
- Clinical data on emerging therapies for EoE
- Greater competence related to
- Incorporating the latest guidelines for diagnosis of EoE
A coordinated team approach to evidence-based management of patients with EoE
Supported by: Takeda Pharmaceutical Company Limited
Shire is now part of Takeda
Additional information and registration to follow.